- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals
Global Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals
Results
56
1 new
High return on equity, past performance and sound balance sheet.
56 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
500488 | ₹27,640.00 | -2.2% | 8.6% | ₹587.3b | ₹28,688.57 | PE45.7x | E11.2% | 1.5% | ||
ORNBV | €49.59 | 12.2% | 15.3% | €6.9b | €50.50 | PE21x | E9.2% | 3.3% | ||
688278 | CN¥79.77 | 11.3% | 46.3% | CN¥32.5b | CN¥87.23 | PE43.8x | E31.7% | 0.5% | ||
500420 | ₹3,157.60 | -3.0% | 26.7% | ₹1.1t | ₹3,646.31 | PE59.3x | E22.6% | 0.9% | ||
600285 | CN¥21.72 | 2.1% | 28.6% | CN¥12.2b | CN¥30.05 | PE18.1x | E16.1% | 3.7% | ||
300896 | CN¥173.03 | -1.7% | -21.9% | CN¥52.2b | CN¥266.90 | PE25.7x | E16.5% | 0% | ||
MEDP | US$347.52 | 5.0% | 16.2% | US$10.5b | US$343.03 | PE29.5x | E11.2% | n/a | ||
300705 | CN¥15.60 | -10.6% | -29.6% | CN¥7.7b | CN¥32.16 | PE15.2x | E25.3% | 1.5% | ||
4015 | ر.س162.80 | 1.4% | 16.6% | ر.س11.4b | ر.س174.38 | PE32.6x | E10.5% | 2.0% | ||
AJANTPHARM | ₹2,832.45 | 0.6% | 28.9% | ₹353.7b | ₹3,018.50 | PE40.4x | E16.7% | 2.0% | ||
1681 | HK$7.78 | 3.2% | 56.2% | HK$6.5b | HK$10.20 | PE7.2x | E14.7% | 7.4% | ||
688578 | CN¥65.85 | 2.9% | 63.1% | CN¥29.6b | CN¥75.00 | PE22.9x | E18.4% | 0.8% | ||
EZZ | AU$2.19 | -6.0% | 265.0% | AU$101.1m | AU$5.45 | PE14.5x | E17.9% | 1.4% | ||
1795 | NT$256.50 | -2.7% | -7.2% | NT$68.1b | NT$394.60 | PE15.7x | E21.6% | 1.8% | ||
A001060 | ₩24,100.00 | 2.6% | -30.1% | ₩603.3b | ₩41,500.00 | PE8.5x | E14.6% | 1.9% | ||
HVO | UK£0.19 | 8.6% | -26.2% | UK£129.3m | UK£0.35 | PE7.4x | E-18.4% | 1.1% | ||
EXEL | US$36.43 | 2.2% | 61.1% | US$10.3b | US$35.61 | PE22.3x | E20.5% | n/a | ||
600436 | CN¥205.74 | -1.6% | -8.5% | CN¥124.1b | CN¥269.57 | PE40.3x | E14.6% | 1.1% | ||
ACAD | US$17.89 | 5.9% | -36.4% | US$2.9b | US$24.95 | PE23.2x | E23.7% | n/a | ||
4587 | JP¥2,190.00 | -4.4% | 58.6% | JP¥283.8b | JP¥3,442.86 | PE16.6x | E1.8% | n/a | ||
3933 | HK$11.62 | 4.9% | 69.9% | HK$21.1b | HK$12.11 | PE6.8x | E5.2% | 5.1% | ||
4519 | JP¥6,570.00 | -3.4% | 16.8% | JP¥10.8t | JP¥7,430.00 | PE27.9x | E6.3% | 1.2% | ||
NATCOPHARM | ₹1,243.00 | -1.1% | 47.9% | ₹222.6b | ₹1,349.17 | PE11.4x | E-18.9% | 0.5% | ||
CPRX | US$22.92 | 3.3% | 53.5% | US$2.7b | US$33.00 | PE19.1x | E17.1% | n/a |